• DAPT plus newer oral anticoagulants increases bleeding risk in ACS

    One year ago - By Healio

    Patients with ACS who were treated with dual antiplatelet therapy plus a newer oral anticoagulant had an increased risk for clinically significant bleeding, according to a meta-analysis published in The American Journal of Cardiology.
    The rate of major adverse CV events was modestly reduced with this treatment.
    Safi U. Khan, MD, internal medicine resident at Guthrie Clinic/Robert Packer Hospital in Sayre, Pennsylvania, and colleagues analyzed data from 31,574 patients with ACS from seven randomized controlled trials that investigated apixaban , rivaroxaban
    Read more ...